Terms: = Endocrine gland cancer AND CCND3, P30281, 896, ENSG00000112576 AND Prognosis
15 results:
1. Interobserver Agreement among Cytopathologists in False-Negative Cases by Cytological Diagnosis with Endoscopic Ultrasound-Guided Fine Needle Aspiration in Solid Pancreatic Lesions.
Shi C; Li S; Chen L; Hong J; Bao J; Xu Z; Xu J; Mei Q
Acta Cytol; 2023; 67(3):240-247. PubMed ID: 37263259
[TBL] [Abstract] [Full Text] [Related]
2. Survival analysis and individualized prediction of survival benefit for pancreatic signet ring cell carcinoma: a population study based on the SEER database.
Nie D; Yang J; Zheng H; Lai G; Wang F; Cao J; Gong C
BMC Gastroenterol; 2023 Mar; 23(1):62. PubMed ID: 36894876
[TBL] [Abstract] [Full Text] [Related]
3. Active surveillance is an excellent management technique for identifying patients with progressive low-risk papillary thyroid microcarcinoma requiring surgical treatment.
Fujishima M; Miyauchi A; Ito Y; Kudo T; Noda T; Sano T; Sasaki T; Kishi T; Nakamura T
Endocr J; 2023 Apr; 70(4):411-418. PubMed ID: 36631086
[TBL] [Abstract] [Full Text] [Related]
4. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
Guo B; Wang Y; Liu W; Zhang S
Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
[TBL] [Abstract] [Full Text] [Related]
5. Long Noncoding RNA LOC554202 Predicts a Poor prognosis and Correlates with Immune Infiltration in Thyroid cancer.
Chen C; Qin L; Xiao MF
Comput Math Methods Med; 2022; 2022():3585626. PubMed ID: 35265169
[TBL] [Abstract] [Full Text] [Related]
6. PRR11 unveiled as a top candidate biomarker within the RBM3-regulated transcriptome in pancreatic cancer.
Olsson Hau S; Wahlin S; Cervin S; Falk V; Nodin B; Elebro J; Eberhard J; Moran B; Gallagher WM; Karnevi E; Jirström K
J Pathol Clin Res; 2022 Jan; 8(1):65-77. PubMed ID: 34379360
[TBL] [Abstract] [Full Text] [Related]
7. Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis.
Wang D; Liu C; Zhou Y; Yan T; Li C; Yang Q; Xu Y; Zhao L; Pei Q; Tan F; Güngör C; Li Y
Radiat Oncol; 2020 May; 15(1):107. PubMed ID: 32404114
[TBL] [Abstract] [Full Text] [Related]
8. Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma.
D'Angelo A; Sobhani N; Roviello G; Bagby S; Bonazza D; Bottin C; Giudici F; Zanconati F; De Manzini N; Guglielmi A; Generali D
PLoS One; 2019; 14(8):e0219566. PubMed ID: 31381571
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic and therapeutic value of disruptor of telomeric silencing-1-like (DOT1L) expression in patients with ovarian cancer.
Zhang X; Liu D; Li M; Cao C; Wan D; Xi B; Li W; Tan J; Wang J; Wu Z; Ma D; Gao Q
J Hematol Oncol; 2017 Jan; 10(1):29. PubMed ID: 28114995
[TBL] [Abstract] [Full Text] [Related]
10. Malnutrition Identified by the Nutritional Risk Index and Poor prognosis in Advanced Epithelial Ovarian Carcinoma.
Yim GW; Eoh KJ; Kim SW; Nam EJ; Kim YT
Nutr Cancer; 2016 Jul; 68(5):772-9. PubMed ID: 27044606
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic value of lymph node ratio in stage IIIC epithelial ovarian cancer with node-positive in a SEER population-based study.
Zhou J; He ZY; Li FY; Sun JY; Lin HX; Wu SG; Chen QH
Oncotarget; 2016 Feb; 7(7):7952-9. PubMed ID: 26788911
[TBL] [Abstract] [Full Text] [Related]
12. Validation and Comparison of Nomograms in Predicting Disease-Specific Survival for Papillary Thyroid Carcinoma.
Lang BH; Wong CK
World J Surg; 2015 Aug; 39(8):1951-8. PubMed ID: 25809064
[TBL] [Abstract] [Full Text] [Related]
13. [Expression and clinical significance of Tspan 1 and Integrin α6 in human pancreatic ductal adenocarcinoma].
Shi G; Dong M; Sheng W; Zhou J; Yu D; Sun W
Zhonghua Wai Ke Za Zhi; 2014 Oct; 52(10):781-6. PubMed ID: 25573220
[TBL] [Abstract] [Full Text] [Related]
14. The number of 131I therapy courses needed to achieve complete remission is an indicator of prognosis in patients with differentiated thyroid carcinoma.
Thies ED; Tanase K; Maeder U; Luster M; Buck AK; Hänscheid H; Reiners C; Verburg FA
Eur J Nucl Med Mol Imaging; 2014 Dec; 41(12):2281-90. PubMed ID: 25030619
[TBL] [Abstract] [Full Text] [Related]
15. Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival.
Song H; Hogdall E; Ramus SJ; Dicioccio RA; Hogdall C; Quaye L; McGuire V; Whittemore AS; Shah M; Greenberg D; Easton DF; Kjaer SK; Pharoah PD; Gayther SA
Clin Cancer Res; 2008 Feb; 14(4):1090-5. PubMed ID: 18281541
[TBL] [Abstract] [Full Text] [Related]
